AdobeStock_1185107043-hero small
Patient support programs (PSPs) are a critical bridge between pharmaceutical manufacturers, providers, payers, and patients. Through provider and patient education, affordability initiatives, digital health platforms, and other important services, PSPs ensure that therapies get to patients who need them and are taken properly and consistently.

In a recent Guidehouse survey, pharmaceutical executives said that these programs are playing a critical role in helping patients afford their medication and have a positive experience. But leaders also cautioned that the industry needs to invest in improving the effectiveness of PSPs, especially those that serve at-risk populations and help providers with an often-complicated reimbursement process.
Download the report

Report insights

59%

of respondents say HUB services are used by at least half of patients enrolled in PSPs

80%

of patients enrolled in a PSP participate in a copay assistance program

52%

of respondents say programs that serve at-risk populations need improvement

Our experts

Let us guide you

Guidehouse is a global organization providing advisory, technology, and managed services to the commercial and public sectors. Purpose-built to serve the national security, financial services, healthcare, energy, and infrastructure industries, we collaborate with leaders to outwit complexity and achieve transformational changes that meaningfully shape the future.

Stay ahead of the curve with news, insights and updates from Guidehouse about issues relevant to your organization and its work.